Nonalcoholic Fatty Liver Disease
📧 Sign up to get email alerts when something new happens for Nonalcoholic Fatty Liver Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: GLP-1 RA on Alcohol Consumption, Metabolism and Liver Parameters in Patients With Obesity and Fatty Liver Disease [NA]
A clinical trial is evaluating a GLP-1 receptor agonist for effects on alcohol consumption, metabolism, and liver parameters in patients wit…
-
CLINICAL_TRIALS withdrawal · 2026-02-23Clinical Trial Update: Shared Pathways Between Non-Alcoholic Fatty Liver Disease and Psoriatic Disease With Guselekumab Therapy
A clinical trial evaluating guselekumab for shared pathways in psoriasis, psoriatic arthritis, and nonalcoholic fatty liver disease has been…
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Patient and Physician Perspectives on Non-Alcoholic Fatty Liver Disease
This document provides a clinical trial update focusing on patient and physician perspectives regarding nonalcoholic fatty liver disease.
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Evaluation of Miricorilant on Liver Fat in Patients With MASLD [Phase 1]
Phase 1 clinical trial evaluating Miricorilant on liver fat in patients with MASLD, including NASH and related conditions; currently recruit…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Personalized Transcranial Magnetic Stimulation (TMS) for Metabolic Dysfunction and Alcohol-Related Liver Disease [NA]
This clinical trial update describes a study evaluating personalized transcranial magnetic stimulation for metabolic dysfunction in alcoholi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-02-03Clinical Trial Update: A Study Between Dapagliflozin and Empagliflozin Effect on NAFLD in Patients With Type 2 Diabetes. [Phase 4]
A Phase 4 study comparing the effects of dapagliflozin versus empagliflozin on nonalcoholic fatty liver disease in patients with type 2 diab…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Effect of a GnRH Analog on Hepatic Steatosis [Phase 4]
A Phase 4 clinical trial is recruiting to assess the effect of a gonadotropin-releasing hormone (GnRH) analog on hepatic steatosis in metabo…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: Measuring Amino Acid and Glucose Metabolism in Healthy Volunteers and NAFLD Patients Using Total-body PET [NA]
A clinical trial update describes measuring amino acid and glucose metabolism in healthy volunteers and patients with nonalcoholic fatty liv…
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: Effects of Empagliflozin on Fibrosis and Cirrhosis in Chronic Hepatitis B Patients [Phase 4]
Phase 4 clinical trial update on empagliflozin for liver fibrosis and cirrhosis in chronic hepatitis B with NAFLD; currently active but not …
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: RTX001 Autologous Engineered Macrophages for Liver Cirrhosis [Phase 1, Phase 2]
RTX001 is an autologous engineered macrophage therapy being investigated in Phase 1/2 trials for end-stage liver disease and liver cirrhosis…
-
CLINICAL_TRIALS trial_result · 2026-01-27Clinical Trial Update: MHT and Liver Function in Postmenopausal Women [NA]
A completed clinical trial investigated the impact of menopausal hormone therapy on liver function in postmenopausal women, with focus on no…
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Investigation of the Efficacy of a Probiotic Mixture in Moderate Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A Mechanistic Trial [Phase 2]
Phase 2 mechanistic clinical trial evaluating a probiotic mixture for metabolic dysfunction-associated steatotic liver disease (MASLD) and n…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Role of Lisinopril in Preventing the Progression of Non-Alcoholic Fatty Liver Disease, RELIEF-NAFLD Study [Phase 2]
Phase 2 RELIEF-NAFLD trial update evaluating lisinopril to prevent progression of non-alcoholic fatty liver disease and nonalcoholic steatoh…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Nonalcoholic Fatty Liver Disease in HIV Database
This entry describes a clinical trial registry study on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in people living w…
-
CLINICAL_TRIALS trial_result · 2026-01-12Clinical Trial Update: A Clinical Study of Efinopegdutide in Participants With Precirrhotic Nonalcoholic Steatohepatitis (NASH) (MK-6024-013) [Phase 2]
Phase 2 study of efinopegdutide in participants with precirrhotic nonalcoholic steatohepatitis (NAFLD/NASH) has completed.
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Quantifying Hepatic Mitochondrial Fluxes in Humans [Phase 4]
A Phase 4 clinical trial at the University of Texas Health Science Center at San Antonio is investigating hepatic mitochondrial fluxes in ad…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: Thermoacoustic Method for Estimating Liver Fat Fraction
Clinical trial investigating a thermoacoustic method to estimate liver fat fraction in MASLD/MASH and nonalcoholic fatty liver disease, curr…
-
CLINICAL_TRIALS trial_result · 2026-01-06Clinical Trial Update: The Impact of Ibutamoren on Nonalcoholic Fatty Liver Disease [Phase 2]
Phase 2 trial studying ibutamoren for nonalcoholic fatty liver disease has completed and posted results. The study was sponsored by Massachu…
-
CLINICAL_TRIALS trial_result · 2025-12-30Clinical Trial Update: Nutritional Education Program for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) [NA]
The document reports an ongoing clinical trial at Taichung Veterans General Hospital evaluating a nutritional education program for metaboli…
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: A Trial to Evaluate the Efficacy, Safety, PK, and PD of HP515 in Non - Alcoholic Fatty Liver Disease ( NASH/MASH ) [Phase 2]
A Phase 2 clinical trial evaluating HP515 for non-alcoholic fatty liver disease, including potential nonalcoholic steatohepatitis, is curren…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Abundance and Distribution of Lipids and Proteins in Nonalcoholic Fatty Liver Disease (NAFLD)
The trial aims to characterize the abundance and distribution of lipids and proteins in nonalcoholic fatty liver disease and is currently en…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: An Imaging-based Quantitative Biomarker Assay for NAFLD in Children [NA]
This clinical trial update describes an imaging-based quantitative biomarker assay being studied for pediatric nonalcoholic fatty liver dise…
-
CLINICAL_TRIALS trial_result · 2025-12-11Clinical Trial Update: Evaluation of the Therapeutic Effects of Curcumin on Changes in Lipid, Metabolic, and Hormonal Profiles, Liver Enzyme Activity, and Ultrasonography Morphology of the Liver in Women With Polycystic Ovary Syndrome and Nonalcoholic Fatty Liver Disease: A Double-blind, Placebo-controlled Clinical Trial [Phase 2, Phase 3]
Clinical trial evaluating curcumin's effects on lipid, metabolic and hormonal profiles and liver morphology in women with PCOS and NAFLD; Ph…
-
CLINICAL_TRIALS research · 2025-12-10Clinical Trial Update: Erdosteine in the Treatment of Nonalcoholic Fatty Liver Disease [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating erdosteine for nonalcoholic fatty liver disease is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: Screening and Follow-up in Patients With HIV Infection Combined With Metabolic Associated Fatty Liver Disease
Recruitment is ongoing for a study examining screening and follow-up in patients with HIV infection and metabolic-associated fatty liver dis…